US Patent Issued to AntlerA Therapeutics on Nov. 3 for "Antibodies that bind to LRP5 proteins and methods of use" (Canadian, American Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,357, issued on Nov. 3, was assigned to AntlerA Therapeutics Inc. (Toronto).

"Antibodies that bind to LRP5 proteins and methods of use" was invented by Sachdev S. Sidhu (Toronto), Guohua Pan (Oakville, Canada), Nish Patel (Scarborough, Canada), Jason Moffat (Toronto), Stephane Angers (Mississauga, Canada), Jarrett Adams (Toronto) and Jagath R. Junutula (Fremont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibodies that specifically bind LRP5 and method of use thereof."

The patent was filed on Aug. 14, 2020, under Application No. 17/634,901.

*For further information, including images, charts and tables, please visit: h...